Impact Factors for Microinvasion in Patients With Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 2, 2010, Pages 467-476

  Wang, Min Hua ^a   Ji, Yuan ^a   Zeng, Zhao Chong ^a   Tang, Zhao You ^a   Fan, Jia ^a   Zhou, Jian ^a   Zeng, Meng Su ^a   Bi, Ai Hong ^a   Tan, Yun Shan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Clinical tumor volume; Hepatocellular carcinoma; Pathologic characteristics; Tumor invasion

Indexed keywords

CLINICAL DATA; CLINICAL TUMOR VOLUME; FETOPROTEIN; FIBROUS CAPSULE; GROSS TUMOR VOLUME; HEPATOCELLULAR CARCINOMA; IMPACT FACTOR; LIVER CIRRHOSIS; PORTAL VEIN INVASIONS; POTENTIAL APPLICATIONS; SURGICAL RESECTION; TNM STAGE; TUMOR GRADES; TUMOR INVASION; TUMOR SIZE;

BLOOD SUBSTITUTES; DOSIMETRY; PLATELETS;

TUMORS;

ALPHA FETOPROTEIN;

ACCURACY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CLINICAL EVALUATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROSCOPY; PATIENT SELECTION; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PLATELET COUNT; PORTAL VEIN; TUMOR BURDEN; YOUNG ADULT;

EID: 73649091763     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.01.057     Document Type: Article

References (31)

1. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
2. Jemal A., Clegg L.X., Ward E., et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Cancer 101 (2004) 3-27
3. Rosu M.R., Dawson L.A., Balter J.M., et al. Alterations in normal liver doses due to organ motion. Int J Radiation Oncology Biol Phys 57 (2003) 1472-1479
4. Liang S.X., Zhu X.D., Xu Z.Y., et al. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiation Oncology Biol Phys 65 (2006) 426-434
5. Kim T.H., Kim D.Y., Park J.W., et al. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol 29 (2006) 568-575
6. Hsu W.C., Chan S.C., Ting L.L., et al. Results of three-dimensional conformal radiotherapy and Thalidomide for advanced hepatocellular carcinoma. Jpn Clin Oncol 36 (2006) 93-99
7. American Joint Committee on Cancer: Liver (including intrahepatic bile ducts). AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York 131-138
8. Cormier J.N., Thomas K.T., Chari R.S., et al. Management of hepatocellular carcinoma. J Gastrointest Surg 10 (2006) 761-780
9. Zeng Z.C., Tang Z.Y., Fan J., et al. A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma. Cancer J 10 (2004) 307-316
10. Dawson L.A. The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother 12 (2008) 96-101
11. Kelsey C.R., Schefter T., Nash R., et al. Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: Implications for stereotactic body radiotherapy. Am J Clin Oncol 28 (2005) 576-580
12. Kanematsu M., Hoshi H., Yamada T., et al. Overestimating the size of hepatic malignancy on helical CT during arterial portography: Equilibrium phase CT and pathology. J Comput Assist Tomogr 21 (1997) 713-719
13. Irani J., Humbert M., Lecocq B., et al. Renal tumor size: Comparison between computed tomography and surgical measurements. Eur Urol 39 (2001) 300-303
14. Iguchi T., Aishima S., Taketomi A., et al. Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma. Am J Surg Pathol 32 (2008) 1675-1682
15. Kubo S., Tanaka H., Shuto T., et al. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today 35 (2005) 216-222
16. Nouso K., Matsumoto E., Kobayashi Y., et al. Risk factors for local and distant recurrence of hepatocellular carcinoma after local ablation therapies. J Gastroenterol Hepatol 23 (2008) 453-458
17. Zeng Z.C., Fan J., Tang Z.Y., et al. Prognostic factors for hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving radiotherapy. Cancer Sci 99 (2008) 2510-2517
18. Reichman T.W., Bahramipour P., Barone A., et al. Hepatitis status, Child-Pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable HCC. J Gastrointest Surg 9 (2005) 638-645
19. O'Suilleabhain C.B., Poon R.T., Yong J.L., Ooi G.C., Tso W.K., and Fan S.T. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 90 (2003) 325-331
20. Sumie S., Kuromatsu R., Okuda K., et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15 (2008) 1375-1382
21. Carr B.I., Buch S.C., Kondragunta V., Pancoska P., and Branch R.A. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: A case cohort study. J Gastroenterol Hepatol 23 (2008) 1259-1266
22. Kitai S., Kudo M., Minami Y., et al. A new prognostic staging system for hepatocellular carcinoma: Value of the biomarker combined Japan integrated staging score. Intervirology 51 (2008) 86-94
23. Changchien C.S., Chen C.L., Yen Y.H., et al. Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: Prognostic features, treatment outcome, and survival. J Gastroenterol 43 (2008) 159-170
24. Sumie S., Kuromatsu R., Okuda K., et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15 (2008) 1375-1382
25. Nakagawara H., Ogawa M., Matsumoto N., et al. Evaluation of malignancy of hepatocellular carcinoma using the ultrasonic B-mode method: Clinical significance of extracapsular invasion of hepatocellular carcinoma using ultrasonography. J Med Ultrasonics 34 (2007) 83-91
26. Ishizaki M., Ashida K., Higashi T., et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch 438 (2001) 574-580
27. Iguchi T., Aishima S., Taketomi A., et al. Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma. Am J Surg Pathol 32 (2008) 1675-1682
28. Ng I.O., Lai E.C.S., Ng M.M.T., and Fan S.T. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 70 (1991) 45-49
29. Ishizaki M., Ashida K., Higashi T., et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch 438 (2001) 574-580
30. Iguchi T., Aishima S., Taketomi A., et al. Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma. Am J Surg Pathol 32 (2008) 1675-1682
31. Grazioli L., Olivetti L., Fugazzola C., et al. The pseudocapsule in hepatocellular carcinoma: Correlation between dynamic MR imaging and pathology. Eur Radiol 9 (1999) 62-67